Why did Tesla approve Elon Musk's $1 trillion pay package?
How is the government shutdown affecting US air travel?
Why is President Trump investigating foreign meatpackers?
What caused Palantir’s stock to crash despite earnings beat?
How is AI spending impacting Meta’s revenue forecast?
What are the effects of FAA flight reductions at major airports?
Why is Wendy’s closing hundreds of stores nationwide?
GLP-1 goliath updates demand for top weight loss drug
thestreet.com/investing/stocks/glp-1-goliath-updates-demand-for-top-weight-loss-drug
Novo Nordisk reported Q3 2025 earnings on November 5, showing continued strong demand for its weight-loss drug Wegovy, despite rising costs and pricing pressure forcing the company to narrow its full-year guidance.
Novo Nordisk financial results
The drugmaker reported a 15% increase in…
This story appeared on thestreet.com, 2025-11-05 18:24:41.